CORD-19:12f1cc78e99a0b82f3225d10abe9a5649f1b33fc / 1289-1418 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12f1cc78e99a0b82f3225d10abe9a5649f1b33fc","sourcedb":"CORD-19","sourceid":"12f1cc78e99a0b82f3225d10abe9a5649f1b33fc","text":"A higher proportion of patients with heart disease than not had IgA antibodies to HCoV-NL63 (6 [16%] versus 2 [3%]; P ‫؍‬ 0.014).","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T9","span":{"begin":0,"end":129},"obj":"Sentence"}],"attributes":[{"subj":"T9","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":129},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T9","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T4","span":{"begin":37,"end":42},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"subj":"T4","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4","span":{"begin":37,"end":50},"obj":"Disease"},{"id":"T58610","span":{"begin":37,"end":50},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"id":"A76884","pred":"mondo_id","subj":"T58610","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"subj":"T4","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T58610","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#93beec","default":true},{"id":"CORD-19-Sentences","color":"#d8ec93"},{"id":"CORD-19-PD-UBERON","color":"#e593ec"},{"id":"CORD-19-PD-MONDO","color":"#93eccb"}]}]}}